Epogen Part B Payments To Be Based On ASP In All Dialysis Centers – CMS
Executive Summary
Medicare will reimburse Amgen's Epogen (epoetin alfa) at the average sales price plus 6% in freestanding and hospital-based dialysis facilities in 2006 under the proposed FDL-1Physician Fee Schedule for 2006, announced Aug. 1
You may also be interested in...
CMS “Actively” Pursuing Discussions On Oncology Demo Extension
The Centers for Medicare & Medicaid Services will base a decision on whether to extend the Medicare "quality of care" oncology demonstration project into 2006 on input from providers, patient groups and other stakeholders
CMS “Actively” Pursuing Discussions On Oncology Demo Extension
The Centers for Medicare & Medicaid Services will base a decision on whether to extend the Medicare "quality of care" oncology demonstration project into 2006 on input from providers, patient groups and other stakeholders
Inhalation Drug Dispensing Fee Likely To Decrease In 2006, CMS Says
CMS expects the dispensing fee for Part B inhalation drugs administered with a nebulizer to drop in 2006 and is soliciting comments on what the new level should be, according to its proposed Medicare FDL-1Physician Fee Schedule for 2006